Table of Content

1 Intravenous Human Immunoglobulin Market Overview
1.1 Product Overview and Scope of Intravenous Human Immunoglobulin
1.2 Intravenous Human Immunoglobulin Segment by Type
1.2.1 Global Intravenous Human Immunoglobulin Market Value Comparison by Type (2024-2034)
1.2.2 Liquid
1.2.3 Powder
1.3 Intravenous Human Immunoglobulin Segment by Application
1.3.1 Global Intravenous Human Immunoglobulin Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Others
1.4 Global Intravenous Human Immunoglobulin Market Size Estimates and Forecasts
1.4.1 Global Intravenous Human Immunoglobulin Revenue 2018-2034
1.4.2 Global Intravenous Human Immunoglobulin Sales 2018-2034
1.4.3 Global Intravenous Human Immunoglobulin Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Intravenous Human Immunoglobulin Market Competition by Manufacturers
2.1 Global Intravenous Human Immunoglobulin Sales Market Share by Manufacturers (2018-2023)
2.2 Global Intravenous Human Immunoglobulin Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Intravenous Human Immunoglobulin Average Price by Manufacturers (2018-2023)
2.4 Global Intravenous Human Immunoglobulin Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Intravenous Human Immunoglobulin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intravenous Human Immunoglobulin, Product Type & Application
2.7 Intravenous Human Immunoglobulin Market Competitive Situation and Trends
2.7.1 Intravenous Human Immunoglobulin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Intravenous Human Immunoglobulin Players Market Share by Revenue
2.7.3 Global Intravenous Human Immunoglobulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Intravenous Human Immunoglobulin Retrospective Market Scenario by Region
3.1 Global Intravenous Human Immunoglobulin Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Intravenous Human Immunoglobulin Global Intravenous Human Immunoglobulin Sales by Region: 2018-2034
3.2.1 Global Intravenous Human Immunoglobulin Sales by Region: 2018-2023
3.2.2 Global Intravenous Human Immunoglobulin Sales by Region: 2024-2034
3.3 Global Intravenous Human Immunoglobulin Global Intravenous Human Immunoglobulin Revenue by Region: 2018-2034
3.3.1 Global Intravenous Human Immunoglobulin Revenue by Region: 2018-2023
3.3.2 Global Intravenous Human Immunoglobulin Revenue by Region: 2024-2034
3.4 North America Intravenous Human Immunoglobulin Market Facts & Figures by Country
3.4.1 North America Intravenous Human Immunoglobulin Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Intravenous Human Immunoglobulin Sales by Country (2018-2034)
3.4.3 North America Intravenous Human Immunoglobulin Revenue by Country (2018-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Intravenous Human Immunoglobulin Market Facts & Figures by Country
3.5.1 Europe Intravenous Human Immunoglobulin Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Intravenous Human Immunoglobulin Sales by Country (2018-2034)
3.5.3 Europe Intravenous Human Immunoglobulin Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intravenous Human Immunoglobulin Market Facts & Figures by Country
3.6.1 Asia Pacific Intravenous Human Immunoglobulin Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Intravenous Human Immunoglobulin Sales by Country (2018-2034)
3.6.3 Asia Pacific Intravenous Human Immunoglobulin Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Intravenous Human Immunoglobulin Market Facts & Figures by Country
3.7.1 Latin America Intravenous Human Immunoglobulin Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Intravenous Human Immunoglobulin Sales by Country (2018-2034)
3.7.3 Latin America Intravenous Human Immunoglobulin Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intravenous Human Immunoglobulin Market Facts & Figures by Country
3.8.1 Middle East and Africa Intravenous Human Immunoglobulin Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Intravenous Human Immunoglobulin Sales by Country (2018-2034)
3.8.3 Middle East and Africa Intravenous Human Immunoglobulin Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Intravenous Human Immunoglobulin Sales by Type (2018-2034)
4.1.1 Global Intravenous Human Immunoglobulin Sales by Type (2018-2023)
4.1.2 Global Intravenous Human Immunoglobulin Sales by Type (2024-2034)
4.1.3 Global Intravenous Human Immunoglobulin Sales Market Share by Type (2018-2034)
4.2 Global Intravenous Human Immunoglobulin Revenue by Type (2018-2034)
4.2.1 Global Intravenous Human Immunoglobulin Revenue by Type (2018-2023)
4.2.2 Global Intravenous Human Immunoglobulin Revenue by Type (2024-2034)
4.2.3 Global Intravenous Human Immunoglobulin Revenue Market Share by Type (2018-2034)
4.3 Global Intravenous Human Immunoglobulin Price by Type (2018-2034)
5 Segment by Application
5.1 Global Intravenous Human Immunoglobulin Sales by Application (2018-2034)
5.1.1 Global Intravenous Human Immunoglobulin Sales by Application (2018-2023)
5.1.2 Global Intravenous Human Immunoglobulin Sales by Application (2024-2034)
5.1.3 Global Intravenous Human Immunoglobulin Sales Market Share by Application (2018-2034)
5.2 Global Intravenous Human Immunoglobulin Revenue by Application (2018-2034)
5.2.1 Global Intravenous Human Immunoglobulin Revenue by Application (2018-2023)
5.2.2 Global Intravenous Human Immunoglobulin Revenue by Application (2024-2034)
5.2.3 Global Intravenous Human Immunoglobulin Revenue Market Share by Application (2018-2034)
5.3 Global Intravenous Human Immunoglobulin Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Baxter
6.1.1 Baxter Corporation Information
6.1.2 Baxter Description and Business Overview
6.1.3 Baxter Intravenous Human Immunoglobulin Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Baxter Intravenous Human Immunoglobulin Product Portfolio
6.1.5 Baxter Recent Developments/Updates
6.2 Grifols
6.2.1 Grifols Corporation Information
6.2.2 Grifols Description and Business Overview
6.2.3 Grifols Intravenous Human Immunoglobulin Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Grifols Intravenous Human Immunoglobulin Product Portfolio
6.2.5 Grifols Recent Developments/Updates
6.3 CSL
6.3.1 CSL Corporation Information
6.3.2 CSL Description and Business Overview
6.3.3 CSL Intravenous Human Immunoglobulin Sales, Revenue and Gross Margin (2018-2023)
6.3.4 CSL Intravenous Human Immunoglobulin Product Portfolio
6.3.5 CSL Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Corporation Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Intravenous Human Immunoglobulin Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Octapharma Intravenous Human Immunoglobulin Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 Biotest
6.5.1 Biotest Corporation Information
6.5.2 Biotest Description and Business Overview
6.5.3 Biotest Intravenous Human Immunoglobulin Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Biotest Intravenous Human Immunoglobulin Product Portfolio
6.5.5 Biotest Recent Developments/Updates
6.6 Kedrion
6.6.1 Kedrion Corporation Information
6.6.2 Kedrion Description and Business Overview
6.6.3 Kedrion Intravenous Human Immunoglobulin Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Kedrion Intravenous Human Immunoglobulin Product Portfolio
6.6.5 Kedrion Recent Developments/Updates
6.7 Hualan Bio
6.6.1 Hualan Bio Corporation Information
6.6.2 Hualan Bio Description and Business Overview
6.6.3 Hualan Bio Intravenous Human Immunoglobulin Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Hualan Bio Intravenous Human Immunoglobulin Product Portfolio
6.7.5 Hualan Bio Recent Developments/Updates
6.8 CNBG
6.8.1 CNBG Corporation Information
6.8.2 CNBG Description and Business Overview
6.8.3 CNBG Intravenous Human Immunoglobulin Sales, Revenue and Gross Margin (2018-2023)
6.8.4 CNBG Intravenous Human Immunoglobulin Product Portfolio
6.8.5 CNBG Recent Developments/Updates
6.9 Shanghai RAAS
6.9.1 Shanghai RAAS Corporation Information
6.9.2 Shanghai RAAS Description and Business Overview
6.9.3 Shanghai RAAS Intravenous Human Immunoglobulin Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Shanghai RAAS Intravenous Human Immunoglobulin Product Portfolio
6.9.5 Shanghai RAAS Recent Developments/Updates
6.10 CBPO
6.10.1 CBPO Corporation Information
6.10.2 CBPO Description and Business Overview
6.10.3 CBPO Intravenous Human Immunoglobulin Sales, Revenue and Gross Margin (2018-2023)
6.10.4 CBPO Intravenous Human Immunoglobulin Product Portfolio
6.10.5 CBPO Recent Developments/Updates
6.11 LFB Group
6.11.1 LFB Group Corporation Information
6.11.2 LFB Group Intravenous Human Immunoglobulin Description and Business Overview
6.11.3 LFB Group Intravenous Human Immunoglobulin Sales, Revenue and Gross Margin (2018-2023)
6.11.4 LFB Group Intravenous Human Immunoglobulin Product Portfolio
6.11.5 LFB Group Recent Developments/Updates
6.12 BPL
6.12.1 BPL Corporation Information
6.12.2 BPL Intravenous Human Immunoglobulin Description and Business Overview
6.12.3 BPL Intravenous Human Immunoglobulin Sales, Revenue and Gross Margin (2018-2023)
6.12.4 BPL Intravenous Human Immunoglobulin Product Portfolio
6.12.5 BPL Recent Developments/Updates
6.13 Tiantan Biological(Sinopharm)
6.13.1 Tiantan Biological(Sinopharm) Corporation Information
6.13.2 Tiantan Biological(Sinopharm) Intravenous Human Immunoglobulin Description and Business Overview
6.13.3 Tiantan Biological(Sinopharm) Intravenous Human Immunoglobulin Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Tiantan Biological(Sinopharm) Intravenous Human Immunoglobulin Product Portfolio
6.13.5 Tiantan Biological(Sinopharm) Recent Developments/Updates
6.14 Taibang Biologic Group
6.14.1 Taibang Biologic Group Corporation Information
6.14.2 Taibang Biologic Group Intravenous Human Immunoglobulin Description and Business Overview
6.14.3 Taibang Biologic Group Intravenous Human Immunoglobulin Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Taibang Biologic Group Intravenous Human Immunoglobulin Product Portfolio
6.14.5 Taibang Biologic Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intravenous Human Immunoglobulin Industry Chain Analysis
7.2 Intravenous Human Immunoglobulin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intravenous Human Immunoglobulin Production Mode & Process
7.4 Intravenous Human Immunoglobulin Sales and Marketing
7.4.1 Intravenous Human Immunoglobulin Sales Channels
7.4.2 Intravenous Human Immunoglobulin Distributors
7.5 Intravenous Human Immunoglobulin Customers
8 Intravenous Human Immunoglobulin Market Dynamics
8.1 Intravenous Human Immunoglobulin Industry Trends
8.2 Intravenous Human Immunoglobulin Market Drivers
8.3 Intravenous Human Immunoglobulin Market Challenges
8.4 Intravenous Human Immunoglobulin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Intravenous Human Immunoglobulin Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Intravenous Human Immunoglobulin Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Intravenous Human Immunoglobulin Market Competitive Situation by Manufacturers in 2024
Table 4. Global Intravenous Human Immunoglobulin Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Intravenous Human Immunoglobulin Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Intravenous Human Immunoglobulin Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Intravenous Human Immunoglobulin Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Intravenous Human Immunoglobulin Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Intravenous Human Immunoglobulin, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Intravenous Human Immunoglobulin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Intravenous Human Immunoglobulin, Product Type & Application
Table 12. Global Key Manufacturers of Intravenous Human Immunoglobulin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Intravenous Human Immunoglobulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous Human Immunoglobulin as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Intravenous Human Immunoglobulin Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Intravenous Human Immunoglobulin Sales by Region (2018-2023) & (K Units)
Table 18. Global Intravenous Human Immunoglobulin Sales Market Share by Region (2018-2023)
Table 19. Global Intravenous Human Immunoglobulin Sales by Region (2024-2034) & (K Units)
Table 20. Global Intravenous Human Immunoglobulin Sales Market Share by Region (2024-2034)
Table 21. Global Intravenous Human Immunoglobulin Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Intravenous Human Immunoglobulin Revenue Market Share by Region (2018-2023)
Table 23. Global Intravenous Human Immunoglobulin Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Intravenous Human Immunoglobulin Revenue Market Share by Region (2024-2034)
Table 25. North America Intravenous Human Immunoglobulin Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Intravenous Human Immunoglobulin Sales by Country (2018-2023) & (K Units)
Table 27. North America Intravenous Human Immunoglobulin Sales by Country (2024-2034) & (K Units)
Table 28. North America Intravenous Human Immunoglobulin Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Intravenous Human Immunoglobulin Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Intravenous Human Immunoglobulin Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Intravenous Human Immunoglobulin Sales by Country (2018-2023) & (K Units)
Table 32. Europe Intravenous Human Immunoglobulin Sales by Country (2024-2034) & (K Units)
Table 33. Europe Intravenous Human Immunoglobulin Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Intravenous Human Immunoglobulin Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Intravenous Human Immunoglobulin Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Intravenous Human Immunoglobulin Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Intravenous Human Immunoglobulin Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Intravenous Human Immunoglobulin Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Intravenous Human Immunoglobulin Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Intravenous Human Immunoglobulin Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Intravenous Human Immunoglobulin Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Intravenous Human Immunoglobulin Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Intravenous Human Immunoglobulin Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Intravenous Human Immunoglobulin Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Intravenous Human Immunoglobulin Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Intravenous Human Immunoglobulin Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Intravenous Human Immunoglobulin Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Intravenous Human Immunoglobulin Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Intravenous Human Immunoglobulin Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Intravenous Human Immunoglobulin Sales (K Units) by Type (2018-2023)
Table 51. Global Intravenous Human Immunoglobulin Sales (K Units) by Type (2024-2034)
Table 52. Global Intravenous Human Immunoglobulin Sales Market Share by Type (2018-2023)
Table 53. Global Intravenous Human Immunoglobulin Sales Market Share by Type (2024-2034)
Table 54. Global Intravenous Human Immunoglobulin Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Intravenous Human Immunoglobulin Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Intravenous Human Immunoglobulin Revenue Market Share by Type (2018-2023)
Table 57. Global Intravenous Human Immunoglobulin Revenue Market Share by Type (2024-2034)
Table 58. Global Intravenous Human Immunoglobulin Price (USD/Unit) by Type (2018-2023)
Table 59. Global Intravenous Human Immunoglobulin Price (USD/Unit) by Type (2024-2034)
Table 60. Global Intravenous Human Immunoglobulin Sales (K Units) by Application (2018-2023)
Table 61. Global Intravenous Human Immunoglobulin Sales (K Units) by Application (2024-2034)
Table 62. Global Intravenous Human Immunoglobulin Sales Market Share by Application (2018-2023)
Table 63. Global Intravenous Human Immunoglobulin Sales Market Share by Application (2024-2034)
Table 64. Global Intravenous Human Immunoglobulin Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Intravenous Human Immunoglobulin Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Intravenous Human Immunoglobulin Revenue Market Share by Application (2018-2023)
Table 67. Global Intravenous Human Immunoglobulin Revenue Market Share by Application (2024-2034)
Table 68. Global Intravenous Human Immunoglobulin Price (USD/Unit) by Application (2018-2023)
Table 69. Global Intravenous Human Immunoglobulin Price (USD/Unit) by Application (2024-2034)
Table 70. Baxter Corporation Information
Table 71. Baxter Description and Business Overview
Table 72. Baxter Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. Baxter Intravenous Human Immunoglobulin Product
Table 74. Baxter Recent Developments/Updates
Table 75. Grifols Corporation Information
Table 76. Grifols Description and Business Overview
Table 77. Grifols Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. Grifols Intravenous Human Immunoglobulin Product
Table 79. Grifols Recent Developments/Updates
Table 80. CSL Corporation Information
Table 81. CSL Description and Business Overview
Table 82. CSL Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. CSL Intravenous Human Immunoglobulin Product
Table 84. CSL Recent Developments/Updates
Table 85. Octapharma Corporation Information
Table 86. Octapharma Description and Business Overview
Table 87. Octapharma Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Octapharma Intravenous Human Immunoglobulin Product
Table 89. Octapharma Recent Developments/Updates
Table 90. Biotest Corporation Information
Table 91. Biotest Description and Business Overview
Table 92. Biotest Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Biotest Intravenous Human Immunoglobulin Product
Table 94. Biotest Recent Developments/Updates
Table 95. Kedrion Corporation Information
Table 96. Kedrion Description and Business Overview
Table 97. Kedrion Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Kedrion Intravenous Human Immunoglobulin Product
Table 99. Kedrion Recent Developments/Updates
Table 100. Hualan Bio Corporation Information
Table 101. Hualan Bio Description and Business Overview
Table 102. Hualan Bio Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. Hualan Bio Intravenous Human Immunoglobulin Product
Table 104. Hualan Bio Recent Developments/Updates
Table 105. CNBG Corporation Information
Table 106. CNBG Description and Business Overview
Table 107. CNBG Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. CNBG Intravenous Human Immunoglobulin Product
Table 109. CNBG Recent Developments/Updates
Table 110. Shanghai RAAS Corporation Information
Table 111. Shanghai RAAS Description and Business Overview
Table 112. Shanghai RAAS Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Shanghai RAAS Intravenous Human Immunoglobulin Product
Table 114. Shanghai RAAS Recent Developments/Updates
Table 115. CBPO Corporation Information
Table 116. CBPO Description and Business Overview
Table 117. CBPO Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. CBPO Intravenous Human Immunoglobulin Product
Table 119. CBPO Recent Developments/Updates
Table 120. LFB Group Corporation Information
Table 121. LFB Group Description and Business Overview
Table 122. LFB Group Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 123. LFB Group Intravenous Human Immunoglobulin Product
Table 124. LFB Group Recent Developments/Updates
Table 125. BPL Corporation Information
Table 126. BPL Description and Business Overview
Table 127. BPL Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 128. BPL Intravenous Human Immunoglobulin Product
Table 129. BPL Recent Developments/Updates
Table 130. Tiantan Biological(Sinopharm) Corporation Information
Table 131. Tiantan Biological(Sinopharm) Description and Business Overview
Table 132. Tiantan Biological(Sinopharm) Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 133. Tiantan Biological(Sinopharm) Intravenous Human Immunoglobulin Product
Table 134. Tiantan Biological(Sinopharm) Recent Developments/Updates
Table 135. Taibang Biologic Group Corporation Information
Table 136. Taibang Biologic Group Description and Business Overview
Table 137. Taibang Biologic Group Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 138. Taibang Biologic Group Intravenous Human Immunoglobulin Product
Table 139. Taibang Biologic Group Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Intravenous Human Immunoglobulin Distributors List
Table 143. Intravenous Human Immunoglobulin Customers List
Table 144. Intravenous Human Immunoglobulin Market Trends
Table 145. Intravenous Human Immunoglobulin Market Drivers
Table 146. Intravenous Human Immunoglobulin Market Challenges
Table 147. Intravenous Human Immunoglobulin Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Intravenous Human Immunoglobulin
Figure 2. Global Intravenous Human Immunoglobulin Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Intravenous Human Immunoglobulin Market Share by Type in 2024 & 2034
Figure 4. Liquid Product Picture
Figure 5. Powder Product Picture
Figure 6. Global Intravenous Human Immunoglobulin Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Intravenous Human Immunoglobulin Market Share by Application in 2024 & 2034
Figure 8. Hospital
Figure 9. Specialty Clinic
Figure 10. Others
Figure 11. Global Intravenous Human Immunoglobulin Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 12. Global Intravenous Human Immunoglobulin Market Size (2018-2034) & (US$ Million)
Figure 13. Global Intravenous Human Immunoglobulin Sales (2018-2034) & (K Units)
Figure 14. Global Intravenous Human Immunoglobulin Average Price (USD/Unit) & (2018-2034)
Figure 15. Intravenous Human Immunoglobulin Report Years Considered
Figure 16. Intravenous Human Immunoglobulin Sales Share by Manufacturers in 2024
Figure 17. Global Intravenous Human Immunoglobulin Revenue Share by Manufacturers in 2024
Figure 18. The Global 5 and 10 Largest Intravenous Human Immunoglobulin Players: Market Share by Revenue in 2024
Figure 19. Intravenous Human Immunoglobulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 20. Global Intravenous Human Immunoglobulin Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 21. North America Intravenous Human Immunoglobulin Sales Market Share by Country (2018-2034)
Figure 22. North America Intravenous Human Immunoglobulin Revenue Market Share by Country (2018-2034)
Figure 23. United States Intravenous Human Immunoglobulin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 24. Canada Intravenous Human Immunoglobulin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 25. Europe Intravenous Human Immunoglobulin Sales Market Share by Country (2018-2034)
Figure 26. Europe Intravenous Human Immunoglobulin Revenue Market Share by Country (2018-2034)
Figure 27. Germany Intravenous Human Immunoglobulin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. France Intravenous Human Immunoglobulin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. U.K. Intravenous Human Immunoglobulin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Italy Intravenous Human Immunoglobulin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Russia Intravenous Human Immunoglobulin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Asia Pacific Intravenous Human Immunoglobulin Sales Market Share by Region (2018-2034)
Figure 33. Asia Pacific Intravenous Human Immunoglobulin Revenue Market Share by Region (2018-2034)
Figure 34. China Intravenous Human Immunoglobulin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Japan Intravenous Human Immunoglobulin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. South Korea Intravenous Human Immunoglobulin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. India Intravenous Human Immunoglobulin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Australia Intravenous Human Immunoglobulin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. China Taiwan Intravenous Human Immunoglobulin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Indonesia Intravenous Human Immunoglobulin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Thailand Intravenous Human Immunoglobulin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Malaysia Intravenous Human Immunoglobulin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Latin America Intravenous Human Immunoglobulin Sales Market Share by Country (2018-2034)
Figure 44. Latin America Intravenous Human Immunoglobulin Revenue Market Share by Country (2018-2034)
Figure 45. Mexico Intravenous Human Immunoglobulin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Brazil Intravenous Human Immunoglobulin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Argentina Intravenous Human Immunoglobulin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Middle East & Africa Intravenous Human Immunoglobulin Sales Market Share by Country (2018-2034)
Figure 49. Middle East & Africa Intravenous Human Immunoglobulin Revenue Market Share by Country (2018-2034)
Figure 50. Turkey Intravenous Human Immunoglobulin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Saudi Arabia Intravenous Human Immunoglobulin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. UAE Intravenous Human Immunoglobulin Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Global Sales Market Share of Intravenous Human Immunoglobulin by Type (2018-2034)
Figure 54. Global Revenue Market Share of Intravenous Human Immunoglobulin by Type (2018-2034)
Figure 55. Global Intravenous Human Immunoglobulin Price (USD/Unit) by Type (2018-2034)
Figure 56. Global Sales Market Share of Intravenous Human Immunoglobulin by Application (2018-2034)
Figure 57. Global Revenue Market Share of Intravenous Human Immunoglobulin by Application (2018-2034)
Figure 58. Global Intravenous Human Immunoglobulin Price (USD/Unit) by Application (2018-2034)
Figure 59. Intravenous Human Immunoglobulin Value Chain
Figure 60. Intravenous Human Immunoglobulin Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed